Adherence to antiepileptic drugs for epileptic patients attending neurology outpatient department in tertiary care center - A prospective observational study

[...]there are notable differences present between adherence and compliance and signify that the patient and general practitioner collaboratively combine to improve the physical health of the patient by effectively combining the guidance given by the practicing physician and patient's health st...

Full description

Saved in:
Bibliographic Details
Published in:National journal of physiology, pharmacy and pharmacology pharmacy and pharmacology, 2021-01, Vol.11 (4), p.1-366
Main Authors: T, Dhivya, M, Shanthi, J, Ezhil
Format: Article
Language:English
Subjects:
Chronic illnesses
Convulsions & seizures
Developing countries
Disease
Drug dosages
Drug therapy
Epilepsy
Family physicians
Inhalers
LDCs
Observational studies
Patient compliance
Prescription drugs
Quality of life
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]there are notable differences present between adherence and compliance and signify that the patient and general practitioner collaboratively combine to improve the physical health of the patient by effectively combining the guidance given by the practicing physician and patient's health status, preferences for care, social lifestyle, and values[79] whereas compliance implies the extent to which a patient's routine medication intake and obedience correctly matches the prescriber's medical advice. Scarcity of resources always hinders the patients from following their decisions to implement treatment including medication regimen cost, problems of accessing prescribed medicine, poor knowledge about the drug availability, and competing their own drug demands. Intentional poor adherence to treatment commonly arises from the faith, interest to take medication regimen, expectation of their disease outcome, and patient attitude and expectations which predominantly influences mental motivation of the people to start and to continue with the treatment regimen in specific time limit. [26] The above high prevalence is due to poor socioeconomic status, inadequate knowledge, cultural and religious beliefs in chronic disease, social stigma prevailing within the people, poor infrastructure of health delivery systems, and scarcity of well-experienced public health workers and field staffs.
ISSN:2320-4672
2231-3206
DOI:10.5455/njppp.2021.11.08227202001122020